MUSC HEALTH COLUMBIA MEDICAL CENTER
1. Target Overview & Investment Thesis
MUSC HEALTH COLUMBIA MEDICAL CENTER is a 332-bed under-performing / distressed in nan, SC with $205.0M in net patient revenue and a -25.3% operating margin. The hospital serves a payer mix of 31.2% Medicare, 7.2% Medicaid, and 61.6% commercial.
Thesis: Undervalued. Our ML models identify $15.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -25.3% to -17.9% (+736bps).
| Net Revenue HCRIS | $205.0M |
| Current EBITDA COMPUTED | $-51.8M |
| Operating Margin COMPUTED | -25.3% |
| Occupancy HCRIS | 27.5% |
| Revenue / Bed COMPUTED | $617K |
| Net-to-Gross HCRIS | 19.3% |
| Distress Probability ML | 54.7% |
2. Market Context & Competitive Position
SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -25.3% places it below the state median. Among 19 size-comparable peers (166-664 beds), the median margin is -0.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (166-664), prioritizing same-state peers. 19 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MUSC HEALTH COLUMBIA MEDICAL C (Target) | SC | 332 | $205.0M | -25.3% |
| LEXINGTON MEDICAL CENTER | SC | 541 | $1.43B | 1.1% |
| PRISMA HEALTH RICHLAND HOSPITA | SC | 600 | $913.3M | 0.4% |
| MCLEOD REGIONAL MEDICAL CENTER | SC | 524 | $792.5M | -4.9% |
| ST. FRANCIS HOSPITAL INC | SC | 327 | $691.4M | 4.9% |
| TRIDENT REGIONAL MEDICAL CENTE | SC | 388 | $637.5M | 16.1% |
| GRAND STRAND REGIONAL MEDICAL | SC | 336 | $602.2M | 32.8% |
| ANMED HEALTH | SC | 367 | $596.7M | -2.3% |
| SELF REGIONAL HEALTHCARE | SC | 290 | $410.1M | 4.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $4.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $4.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $4.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $131K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-51.8M |
| + RCM Uplift | +$15.1M |
| Pro Forma EBITDA | $-36.7M |
| Current Margin | -25.3% |
| Pro Forma Margin | -17.9% |
| WC Released (1x) | $7.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-79.7M | $-190.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-79.7M | $-235.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-71.7M | $-211.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-71.7M | $-252.3M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-87.7M | $-240.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-87.7M | $-292.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 27.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 54.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 19 hospitals with 166-664 beds
- Same-state prioritization (n=20)
- Comp margins: P25=-7.1% / P50=-0.0% / P75=4.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.